EMA and heads of national competent authorities discuss consequences of Brexit: key principles and w
The European Medicines Agency (EMA) organised an information meeting 27/4/2017 with members of its Management Board and heads of the National Competent Authorities (NCAs) of the EU/EEA Member States. The goal was to start discussing how the work related to the evaluation and monitoring of medicines will be shared between Member States in view of the United Kingdom’s (UK) withdrawal from the European Union.
#PharmaNews #LegislationPharmacovigilance #RegulatoryAffairsHuman #LegislationRegulatoryAffairs
